VTRO (Vitro Biopharma) EPS (Basic): $0.00 (TTM As of Oct. 2022)


What is Vitro Biopharma EPS (Basic)?

Vitro Biopharma VTRO EPS (Basic) is $0.00 as of Oct. 2022. The stock has 6 warning signs investors should review.

Vitro Biopharma's basic earnings per share (Basic EPS) for the three months ended in Oct. 2022 was $0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Oct. 2022 was $0.00.

Vitro Biopharma's EPS (Diluted) for the three months ended in Oct. 2022 was $0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Oct. 2022 was $0.00.

Vitro Biopharma's EPS without NRI for the three months ended in Oct. 2022 was $0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Oct. 2022 was 0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Vitro Biopharma's highest 3-Year average EPS without NRI Growth Rate was 26.30% per year. The lowest was -30.10% per year. And the median was 10.60% per year.

Vitro Biopharma  (AMEX:VTRO) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Vitro Biopharma EPS (Basic) Related Terms

Vitro Biopharma EPS (Basic) Historical Data

* Premium members only.

The historical data trend for Vitro Biopharma's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vitro Biopharma EPS (Basic) Chart

Vitro Biopharma Annual Data
Trend Oct09 Oct10 Oct11 Oct12 Oct13 Oct14 Oct15 Oct17 Oct21 Oct22
EPS (Basic)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.01 -0.01 0.00 -0.09 -0.07

Vitro Biopharma Quarterly Data
Oct00 Oct01 Oct02 Oct03 Oct04 Oct05 Oct06 Oct07 Oct08 Oct09 Oct10 Oct11 Oct12 Oct13 Oct14 Oct15 Oct17 Oct21 Oct22
EPS (Basic) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Vitro Biopharma EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Vitro Biopharma's Basic EPS for the fiscal year that ended in Oct. 2022 is calculated as

Basic EPS (A: Oct. 2022 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-6.86-0.905)/107.725
=-0.07

Vitro Biopharma's Basic EPS for the quarter that ended in Oct. 2022 is calculated as

Basic EPS (Q: Oct. 2022 )=(Net Income-Preferred Dividends)/Shares Outstanding (Basic Average)
=(-6.86-0.905)/107.725
=-0.07

EPS (Basic) for the trailing twelve months (TTM) ended in Oct. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EPS (Basic) →
What does a EPS (Basic) of $0.00 mean?
Vitro Biopharma (VTRO) has a EPS (Basic) of $0.00 as of Oct. 2022. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Vitro Biopharma and its competitors.
Is Vitro Biopharma's EPS (Basic) too high?
Vitro Biopharma's current EPS (Basic) is $0.00.
How does Vitro Biopharma's EPS (Basic) compare to ?
Vitro Biopharma's EPS (Basic) of $0.00 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EPS (Basic) for a Biotechnology company?
A good EPS (Basic) depends on the Biotechnology industry context. However, EPS (Basic) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EPS (Basic) mean?
A high EPS (Basic) can signal that a stock is expensive relative to its fundamentals. Earnings per share (basic) equals net income divided by the standard, non-diluted average shares outstanding. View historical data on Vitro Biopharma and its competitors. Vitro Biopharma's current EPS (Basic) is $0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vitro Biopharma stock overvalued right now?
Vitro Biopharma (VTRO) has a current EPS (Basic) of $0.00. The current EPS (Basic) is $0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EPS (Basic) calculated?
EPS (Basic) is calculated from a company's financial statements. For Vitro Biopharma (VTRO), the current EPS (Basic) is $0.00 as of Oct. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vitro Biopharma Business Description

Comparable Companies
Address 4621 Technology Drive, Golden, CO, USA, 80403
Vitro Diagnostics Inc is a US-based company, which is dedicated to providing high-quality commercialized cell lines, media, and stem cell technology for applications in stem cell research, drug discovery, and therapies. In addition, it also provides tools for clinical development focused on Mesenchymal Stem Cells (MSCs). Further, it offers cancer-associated fibroblasts (CAFs), which are used in the discovery of a new type of CAFs present in pancreatic cancer tumors, called pancreatic stellate cells. Geographically business activities are functioned through the region of United States.